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The Serpin a1-Proteinase Inhibitor Is a Critical
Substrate for Gelatinase B/MMP-9 In Vivo
intracellular protein BP230 (Sawamura et al., 1991; Ta-
naka et al., 1991) and the 180 kDa transmembrane pro-
tein BP180 (BPAG2, or type XVII collagen) (Diaz et al.,
Zhi Liu,*# Xiaoye Zhou,* Steven D. Shapiro,†‡
J. Michael Shipley,† Sally S. Twining,§
Luis A. Diaz,* Robert M. Senior,†
1990; Giudice et al., 1992). In BP the separation of theand Zena Werbk
epidermis from the dermis occurs within the lamina lu-*Department of Dermatology
cida of the basement membrane and is accompaniedUniversity of North Carolina
by destruction of hemidesmosomal and extracellularChapel Hill, North Carolina 27599
matrix components and formation of blisters (Schaum-†Department of Medicine
burg-Lever et al., 1972; Dvorak et al., 1982). Proteinases‡Departments of Pediatrics and Cell Biology
released from infiltrating inflammatory cells have been
Washington University School of Medicine
implicated in the tissue damage in these lesions (Gam-
St. Louis, Missouri 63110 mon, 1989): BP blister fluids and lesional/perilesional
§Department of Biochemistry sites contain both serine proteinases, such as neutrophil
Medical College of Wisconsin elastase (NE) and plasmin, and MMPs, such as GB and
Milwaukee, Wisconsin 53226 gelatinase A/MMP-2 (Oikarinen et al., 1983; Welgus et
kDepartment of Anatomy al., 1986; Grando et al., 1989a, 1989b; Gissler et al.,
University of California, San Francisco 1992; Kramer and Reinartz, 1993; Stahle-Backdahl et
San Francisco, California 94143 al., 1994).
We used a mouse model that recapitulates the key
features of human BP (Liu et al., 1993). Subepidermal
blister formation triggered by anti-mouse BP180 IgGSummary
(anti-mBP180) depends on activation of complement
and polymorphonuclear leukocyte (PMN) infiltration (LiuWe have identified the key protein substrate of gela-
et al., 1995b, 1997). Mice with targeted null mutations
tinase B/MMP-9 (GB) that is cleaved in vivo during in either GB (Liu et al., 1998) or NE (Liu et al., 2000) do
dermal–epidermal separation triggered by antibodies not form blisters. These results demonstrate that GB
to the hemidesmosomal protein BP180 (collagen XVII, and NE are required for blister formation. Although GB
BPAG2). Mice deficient in either GB or neutrophil elas- and NE degrade numerous extracellular components of
tase (NE) are resistant to blister formation in response the basement membrane zone (Liu et al., 1998, 2000;
to these antibodies in a mouse model of the autoim- Vu and Werb, 1998), the critical substrates for these two
mune disease bullous pemphigoid. Disease develops enzymes involved in the blister formation have not been
upon complementation of GB2/2 mice with NE2/2 neu- determined. In this study we have determined functional
trophils or NE2/2 mice with GB2/2 neutrophils. Only interactions between GB and NE in dermal–epidermal
separation (blistering) and identified the key substrateNE degrades BP180 and produces dermal–epidermal
for GB in experimental BP.separation in vivo and in culture. Instead, GB acts
upstream to regulates NE activity by inactivating a1-
proteinase inhibitor (a1-PI). Excess NE produces le- Results
sions in GB2/2 mice without cleaving a1-PI. Excess
a1-PI phenocopies GB and NE deficiency in wild-type Both GB and NE Are Required for Subepidermal
mice. Blister Formation
We first assessed the relationship between GB and NE
during the skin disease process by injecting GB2/2 andIntroduction
NE2/2 mice with pathogenic anti-mBP180 IgG, then
2 hr later reconstituting them with 5 3 105 PMN fromMatrix metalloproteinases (MMPs) are critical regulators
GB1/1, GB2/2, NE1/1, or NE2/2 mice. When these miceof physiologic and pathologic events (Werb, 1997). One
were then assessed for subepidermal blistering 12 hrof the outstanding questions in disease pathogenesis
after IgG injection, GB2/2 mice reconstituted with PMNmediated by MMPs is the identity of their critical sub-
from either GB1/1 or NE2/2 mice developed subepider-strate targets in vivo. Gelatinase B/MMP-9 (GB) is in-
mal blisters (Figure 1, Table 1). In contrast, GB2/2 micevolved in a relatively confined set of such events in
reconstituted with PMN from GB2/2 mice remainedvivo, including angiogenesis during endochondral bone
resistant. NE2/2 mice reconstituted with PMN fromformation and autoimmune subepidermal blistering (Liu
NE1/1 mice or PMN from GB2/2 mice also developedet al., 1998; Vu et al., 1998). In the present study, we
blisters. In contrast, the anti-mBP180 IgG failed to in-set out to identify the in vivo substrates in an immune
duce skin lesions in NE2/2 mice reconstituted with PMNinflammatory skin disease, called bullous pemphigoid
from NE2/2 mice. The cross-complementation suggests(BP), that is initiated by deposition of autoantibodies and
that NE and GB act in the same pathway.complement components at the basement membrane
zone (Jordon et al., 1985). BP autoantibodies recognize
two major hemidesmosomal components, the 230 kDa Degradation of BP180 Antigen Depends on Both
NE and GB
BP180 antigen was cleaved during subepidermal blis-# To whom correspondence should be addressed (e-mail: zhiliu@
med.unc.edu). tering, as determined by immunoblotting of extracts of
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Figure 1. Histological Evaluation of Neonatal
GB2/2 and NE2/2 Mice Injected with Patho-
genic anti-mBP180 IgG and Reconstituted
with Mouse PMN
(A) Pathogenic rabbit anti-murine BP180 IgG
(i.d. injection, 2.5 mg/g body weight) pro-
duced subepidermal blistering in neonatal
GB2/2 mice reconstituted with 5 3 105 PMN
from (a) GB1/1, (c) NE2/2, but not (b) GB2/2
mice.
(B) Pathogenic rabbit anti-murine BP180 IgG
(i.d. injection, 2.5 mg/g body weight) pro-
duced clinical (data not shown) and histologi-
cal subepidermal blistering in neonatal NE2/2
mice reconstituted with 5 3 105 PMN from
(a) NE1/1, (c) GB2/2, but not (b) NE2/2 mice
(3184). Insets, higher magnifications of H&E
staining sections, demonstrate infiltrating
PMN in the dermis (3920). Basal keratinocyte
(arrow), dermis (d), epidermis (e), blister vesi-
cle (v), PMN (arrowhead).
the lesional and nonlesional skin of the injected animals NE2/2 mice reconstituted with PMN from NE1/1 mice,
NE2/2 mice reconstituted with PMN from GB2/2 miceusing anti-mBP180 IgG (Figure 2A). This raises the ques-
tion of which enzyme degrades BP180 during blister and GB2/2 mice reconstituted with PMN from NE2/2
mice (Figure 2A). In contrast, the nonlesional skin ex-formation. Both intact (180 kDa) and degraded mBP180
(100 kDa) were present in lesional skin from NE1/1 mice, tracts of NE2/2 mice, NE2/2 mice reconstituted with PMN
Table 1. Summary: The Relationship between GB and NE in Experimental BP
Genotype of Genotype of PMN Number of Mean Disease
Host Micea Reconstituted Mice Activity Scoreb
GB1/1 — 12 3
GB2/2 — 12 0
5 3 105 GB1/1 8 3
5 3 105 GB2/2 8 0
2.5 3 106 GB2/2 8 2
5 3 105 NE2/2 8 3
NE1/1 — 12 3
NE2/2 — 12 0
5 3 105 NE1/1 8 3
5 3 105 NE2/2 8 0
2.5 3 106 NE2/2 8 0
5 3 105 GB2/2 8 3
a Neonatal GB-sufficient (GB1/1), GB-deficient (GB2/2), NE-sufficient (NE1/1), and NE-deficient (NE2/2) mice were injected i.d. with pathogenic
anti-mBP180 IgG. Purified mouse PMN from GB1/1, GB2/2, NE1/1, or NE2/2 mice were given i.d. 2 hr after IgG injection.
b Injected animals were examined clinically 12 hr after IgG injection and disease activity scored as described in Experimental Procedures.
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test the proteinase dependency of subepidermal blis-
tering directly, neonatal mouse skin sections were incu-
bated with purified human NE or mouse GB and exam-
ined histologically at various time points over a 24 hr
period. The skin sections treated with NE, but not with
GB or MEM alone, showed complete detachment of the
epidermis from the dermis at 24 hr (Figure 2B). The NE-
induced dermal–epidermal separation was completely
blocked by an NE inhibitor, a1-PI, but not by a metallo-
proteinase inhibitor, EDTA. These results suggest that
NE, and not GB, is critical for mBP180 antigen degrada-
tion and dermal–epidermal separation in experimental
BP. This raises the question of how GB functions in this
process.
GB and NE Facilitate PMN Recruitment
One possibility is that GB is required for recruitment
of PMN into the lesions. Therefore, we determined the
relative number of PMN in skin from GB1/1, GB2/2,
NE1/1, and NE2/2 mice injected with pathogenic anti-
mBP180 IgG, and examined clinically for blisters 12 hr
later. As expected, GB1/1 and NE1/1 mice developed
subepidermal blisters, while GB2/2 and NE2/2 mice were
resistant (Figure 3 and Table 1). When skin samples
were analyzed for PMN infiltration by assay of MPO, we
found significantly more PMN were recruited into the
lesional skin sites in the GB1/1 and NE1/1 mice than into
the nonlesional sites in GB2/2 and NE2/2 mice (Figure
3A). Moreover, GB was readily detected in the skin sam-
ples from GB1/1 and NE1/1, and weakly in NE2/2, but not
GB2/2 mice by gelatin zymography (Figure 3B). Similarly,
NE activity was significantly elevated in the skin of
GB1/1 and NE1/1, but not of GB2/2 and NE2/2 mice
(Figure 3C). However, at 4 hr after IgG injection, GB2/2
and NE2/2 mice had a similar number of infiltrating PMN
Figure 2. BP180 Cleavage and Epidermal–Dermal Separation in the skin as compared to wild-type control mice, as
(A) To identify BP180 degradation in the lesional skin of experimental shown previously (Liu et al., 1998, 2000). These data
BP neonatal NE2/2 (lanes 1–4), NE1/1 (lane 5), and GB2/2 (lanes 6–7) indicate that both GB and NE contribute to the recruit-
mice were injected i.d. with anti-mBP180 IgG. 2 hr later, the IgG- ment of PMN to form the blisters. In their absence, re-
injected mice were reconstituted with 5 3 105 mouse PMN. Skin
cruitment of PMN and, therefore available NE and GB,samples were obtained at 12 hr after IgG injection and protein ex-
are reduced.tracts (15 mg/lane) were analyzed by immunoblotting using the anti-
mBP180 IgG. Both the intact and degraded BP180 were seen in
lesional skin samples of IgG-injected NE1/1 mice (lane 5), NE2/2
GB Acts Upstream of NEmice injected with IgG and reconstituted with PMN from NE1/1 (lane
Our data show that NE alone is able to produce dermal–2) and GB2/2 (lane 4) mice, and GB2/2 mice injected with IgG and
epidermal separation in vitro. If this is the case in vivo,reconstituted with PMN from NE2/2 (lane 6) mice. In contrast, no
then we should be able to get blistering induced by NEdegraded BP180 was found in skin samples of IgG-injected NE2/2
mice (lane 1), IgG-injected NE2/2 mice reconstituted with PMN from in the absence of GB. Although blisters do not form in
NE2/2 mice (lane 3), or GB2/2 mice reconstituted with PMN from GB2/2 mice, recruitment of PMN is also reduced in
GB2/2 mice (lane 7). GB2/2 mice, and 5 3 105 GB2/2 PMN are unable to rescue
(B) To generate BP-like dermal–epidermal separation in mouse skin the GB2/2 phenotype. However, when we reconstituted
by NE neonatal mouse skin sections were incubated in (a) MEM anti-mBP180 treated GB2/2 mice with five times as many
alone with (b) 25 mg/ml NE or (c) 80 mg/ml GB at 378C for 24 hr and
(2.5 3 106) GB2/2 PMN, skin lesions appeared in thewere examined by H&E staining. Dermal–epidermal separation was
absence of GB (compare Figure 4A with Figure 1A; Tableobserved in sections treated with NE, but not GB. Control sections
1) and cleaved mBP180 antigen was detected in skinincubated in MEM without proteinases showed no dermal–
lysates (Figure 4B). In contrast, 2.5 3 106 NE2/2 PMNepidermal separation (panel A). Site of basal keratinocytes (arrow),
epidermis (e), dermis (d), blister vesicle (V) (3368). did not reconstitute NE2/2 mice, and extracts from their
skin showed only intact mBP180 antigen. These results
demonstrate that GB2/2 mice can develop skin blistersfrom NE2/2 mice and GB2/2 mice reconstituted with
when compensated with a sufficient number of GB2/2PMN from GB2/2 mice showed only intact mBP180 an-
(but NE1/1) PMN as a source of NE, while same numbertigen.
of NE2/2 (but GB1/1) PMN did not induce blisters in
NE2/2 mice. Thus, GB acts upstream of NE, but playsNE, but not GB, Produces Dermal–Epidermal
a minimal role in the direct degradation of extracellularSeparation
proteins that cause subepidermal blistering in experi-Both NE (Liu et al., 2000) and GB (Stahle-Backdahl et
al., 1994) degrade recombinant BP180 in solution. To mental BP in this inflammatory cascade.
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NE, in turn, could degrade extracellular components in
the basement membrane zone, leading to subepidermal
blister formation. In GB2/2 mice, the high level of active
a1-PI is due to lack of GB activity, while in NE2/2 mice
it is due to the decreased levels of GB because of fewer
PMN present in the skin at 12 hr (see Figure 3A) and
the lack of NE (which forms a complex with a1-PI).
Proteolytic Inactivation of a1-PI Is GB Dependent
To determine if GB is involved in a1-PI inactivation dur-
ing lesion formation, we analyzed the skin extracts of
GB2/2 mice injected with pathogenic IgG and reconstitu-
ted with PMN for a1-PI by immunoblotting. Both native
and degraded a1-PI were present in lesional skin of
GB1/1 mice and GB2/2 mice reconstituted with 5 3 105
PMN from GB1/1 or NE2/2 mice (Figure 4D). In contrast,
the nonlesional skin extracts of GB2/2 mice and GB2/2
mice reconstituted with 5 3 105 PMN from GB2/2 mice
showed only native a1-PI. Significantly, GB2/2 mice,
which were reconstituted with 2.5 3 106 PMN from GB2/2
mice and developed subepidermal blisters, but showed
only native a1-PI. These results reveal the GB-depen-
dent proteolytic inactivation of a1-PI during lesion for-
mation. The finding that excess NE is able to circumvent
the requirement for GB further suggests that active NE
is limiting in GB2/2 mice and that NE is the major enzyme
in basement membrane zone destruction in experimen-
tal BP.
a1-PI Inhibits Development of Experimental Blisters
If a1-PI is the critical substrate of GB, then administra-
tion of excess a1-PI to wild-type mice should pheno-
copy the response of GB2/2 and NE2/2 mice. Injection
of a1-PI into mice injected with anti-mBP180 blocked
subepidermal blistering (Figure 5A; mean diseaseFigure 3. Comparison of Levels of PMN Infiltration in the Lesional
score 5 3 for controls [n 5 8]; disease score 5 0 forSkin in Experimental BP
a1-PI injected [n 5 8]). In contrast, administration ofGB1/1, GB2/2, NE1/1, and NE2/2 mice were injected with pathogenic
a1-antichymotrypsin (a1-AC), an inhibitor of the PMNanti-mBP180 IgG. Recruitment of PMN (as assayed by MPO, GB
enzyme cathepsin G was without effect. At 4 hr afterand NE in the IgG injection sites) was analyzed at 12 hr after IgG
injection. injection, there were similar numbers of PMN in animals
(A) MPO activity assay showed significantly higher levels of PMN with or without a1-PI pretreatment, as monitored by
recruitment in the lesional skin of GB1/1 (bar 1) and NE1/1 (bar 3) extractable MPO activity (Figure 5B). However, at 12 hr,
mice as compared to GB2/2 (bar 2) and NE2/2 (bar 4) mice. the animals treated with a1-PI had significantly lower
(B) Gelatin zymography revealed GB bands in lesional skin samples levels of MPO activity than control mice and no blisters.
of GB1/1 (lane 1), NE1/1 (lane 3), and nonlesional skin samples of
These data indicate that initial PMN recruitment is inde-NE2/2 (lane 4), but not in nonlesional skin samples of GB2/2 (lane
pendent of a1-PI, but later, PMN recruitment is not sus-2). 12 mg protein/lane for lanes 1 and 2; 30 mg protein/lane for lanes
tained in the presence of excess a1-PI and blisters do not3 and 4.
develop. This is exactly the phenotype seen in GB2/2(C) NE activity assay was significantly higher in the lesional skin of
GB1/1 (bar 1) and NE1/1 (bar 3) mice, as compared to the skin of and NE2/2 mice (Figure 3). Pretreatment of a1-PI with
GB2/2 (bar 2) and NE2/2 (bar 4) mice. (n 5 8 for each group, *p , gelatinase B eliminated its inhibitory activity on blister
0.001, for paired samples: bar 1 versus 2 and 3 versus 4). formation (data not shown),
Discussion
a1-Proteinase Inhibitor (a1-PI) Is Elevated in Skin
of GB2/2 and NE2/2 Mice Treated with Anti-mBP180 Our study definitively establishes a1-PI as a key sub-
strate for GB in vivo. GB was discovered as an MMPThe experiments described above indicate that NE is
necessary to produce blistering. Why, then, are 5 3 105 that can cleave type IV and V collagens and denatured
collagens (gelatin) in vitro (reviewed in Vu and WerbGB2/2 PMN insufficient as a source of NE in GB2/2 mice?
One possibility is that endogenous inhibitors of NE are 1998). Subsequently, GB has been shown to cleave
other ECM substrates, such as BP180, and non-ECMpresent in excess. The serpin a1-PI, which is the princi-
pal plasma inhibitor of NE, was present at significantly proteins, such as serpins, and to activate TGF-b in vitro
(Vu and Werb 1998; Yu and Stamenkovic, 2000). Thehigher levels in the nonlesional skin of GB2/2 and NE2/2
mice, when PMN proteinases are deficient, than in blis- pathogenic anti-mBP 180 IgG dictates the localized de-
granulation of proteinases at high concentration fromters of GB1/1 and NE1/1 mice (Figure 4C). A possible
explanation is that the role of GB in blister formation is PMN adhering to the immune complexes formation at
the dermal–epidermal junction. The surprising outcometo inactivate a1-PI, allowing NE activity to function. Free
MMP-9 Inactivates Serpins In Vivo
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Figure 4. Dependence of a1-PI Degradation on GB
GB1/1, GB2/2, NE1/1, and NE2/2 mice were injected i.d. with pathogenic IgG. 2 hr later, GB2/2 and NE2/2 mice were reconstituted with 2.5 3
106 mouse PMN. These animals were examined at 12 hr after IgG injection.
(A) Clinical and histological examination showed that IgG-injected GB2/2 mice reconstituted with 2.5 3 106 PMN from GB2/2 mice developed
skin lesions (a and b), while the NE2/2 reconstituted with 2.5 3 106 PMN from NE2/2 mice remained resistant to experimental BP (c and d).
Site of basal keratinocytes (arrow), epidermis (e), dermis (d), blister vesicle (V), PMN (arrowhead).
(B) Immunoblotting using the anti-mBP180 IgG demonstrates that both the intact and degraded BP180 were present in lesional skin extracts
of GB2/2 mice reconstituted with 2.5 3 106 GB2/2 PMN (lane 1), but not in skin extracts of NE2/2 mice reconstituted with 2.5 3 106 NE2/2
PMN (lane 2). 15 mg protein/lane.
(C) Reverse zymography (38 mg protein/lane) protein showed significantly higher levels of a1-PI in the nonlesional skin of GB2/2 (1.90 6 0.24
units/mg protein) and NE2/2 (1.17 6 0.13 units/mg) mice, as compared to the lesional skin of GB1/1 (0.53 6 0.06 units/mg; p , 0.001) and
NE1/1 (0.41 6 0.05 units/mg; p , 0.001) mice.
(D) Immunoblotting using the anti-a1-PI IgG shows both the intact and degraded a1-PI in lesional skin samples of GB1/1 mice injected with
IgG (lane 6) and GB2/2 mice injected with IgG and reconstituted with 5 3 105 PMN from GB1/1 (lane 2) or NE2/2 (lane 5) mice. In contrast,
only the intact a1-PI was found in skin samples of GB2/2 mice injected with pathogenic IgG only (lane 1) or IgG-injected GB2/2 mice reconstituted
with 5 3 105 PMN from GB2/2 mice (lane 3). GB2/2 mice reconstituted with 2.5 3 106 PMN from GB2/2 mice developed blisters, but showed
no detectable degraded a1-PI in the skin (lane 4).
of the present study is that BP180 in native configura- that are frequently coexpressed, each enzyme is re-
stricted to a very specific function, discernable in ani-tion, with other ECM proteins in the basement mem-
brane zone of the skin is not a critical substrate for GB mals with null-mutations in MMPs. Only one substrate,
a-defensin, has been identified previously as an MMPin vivo. Instead GB inactivates a1-PI, a serpin synthe-
sized by the liver and delivered to tissues via the plasma. substrate in vivo (Wilson et al., 1999).
Substrates may be different in different sites in vivo.The broad substrate specificity of GB against ECM
substrates in vitro, yet highly restricted specificity in For example, matrilysin/MMP-7 cleaves and activates
a-defensin in Paneth cells of the intestine (Wilson et al.,vivo may represent a general paradigm for other MMPs.
This may explain why, despite the large number of MMPs 1999), while Fas ligand cleavage is implicated during
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the proteolytic inactivation of a1-PI by GB, underlies the
pathology of an inflammatory skin disorder, BP. Our
study elucidates the mechanisms by which GB and NE
promote dermal–epidermal separation and blistering in
a mouse model of BP and establishes an epistatic rela-
tionship between the two enzymes: The key role of GB
is the inactivation of a1-PI, whereas NE is the major
tissue-damaging enzyme that produces BP180 degra-
dation and dermal–epidermal junction separation. Al-
though, in vitro, both GB and NE are able to cleave
the components of extracellular matrix and recombinant
BP180 antigen, which is the main target of pathogenic
antibodies (Stahle-Backdahl et al., 1994; Liu et al., 2000),
GB does not cleave mBP180 in vivo or produce dermal–
epidermal separation in mouse skin sections. Instead,
GB contributes to tissue damage indirectly by inactivat-
ing a1-PI, allowing unchecked activity of NE to cleave
structural proteins, including BP180 antigen, in the der-
mal–epidermal junction. Reconstitution of wild-type
mice with excess a1-PI develops the resistance to blis-
ter formation seen in GB2/2 and NE2/2 mice.
Our data also point to a second function of GB in
regulating experimental blister formation, that of sus-
taining recruitment of inflammatory PMN. GB is not re-
quired for acute recruitment of PMN in lungs, perito-
neum, or skin (Betsuyaku et al., 1999). However,
although initial recruitment of PMN at 4 hr is normal
in both NE- and GB-deficient mice, recruitment is not
sustained in the absence of either NE or GB. Thus, GB
collaborates with NE in generating and/or maintaining
chemoattractant levels in the lesions. While the comple-
ment fragments C5a and C3a, generated immediately
Figure 5. In Vivo Inhibition of Dermal–Epidermal Separation by after the administration of the toxic antibody are potent
a1-PI chemoattractant, other factors probably take over as
(A) Histology of mouse skin sections: (a) Blister in mice injected with the reaction develops. Fragments of cleaved proteins
pathogenic IgG alone. (b) No blister in mice pretreated with a1-PI. may contribute to the later phase of PMN recruitment.
(c) Blister in mice pretreated with the neutrophil cathepsin G inhibi-
Indeed, cleaved a1-PI is a potent chemoattractant fortor, a1-antichymotrypsin (a1-AC). Site of basal keratinocytes
PMN (Banda et al., 1988).(arrow), epidermis (e), dermis (d), blister vesicle (V).
Several MMPs including collagenase, macrophage(B) MPO assay at 4 hr (hatched bars) after injection of wild-type
elastase, matrilysin, stromelysin-1, and stromelysin-3mice with pathogenic IgG, shows that the same number of PMN
were present in mice pretreated with a1-PI (bar 3), as those injected also can cleave a1-PI and destroy its NE inhibitory activ-
with PBS alone (bar 1) and a1-AC (bar 5). However, by 12 hr (black ity (Banda et al., 1980, 1987; Ossanna et al., 1986; Po-
bars) the mice pretreated with a1-PI (bar 4) had significantly fewer tempa et al., 1986; Knauper et al., 1990; Mast et al.,
PMN than controls (bars 2 and 6) (*, p , 0.001). n 5 8 for each 1991; Okada et al., 1992; Pei et al., 1997). GB is not
group. particularly efficient in a1-PI inactivation, compared to
other MMPs (Mast et al., 1991), yet in this specific site
it is most effective. Whether MMPs can contribute to
prostate involution following castration (Powell et al., experimental blister formation remains to be deter-
1999). During healing of skin wounds, stromelysis-1/ mined. a1-PI can be inactivated not only by proteolysis,
MMP-3 mediates wound closure by regulating the for- but also by the reactive oxidant HOCl (Morihara et al.,
mation of an actin “purse-string” by dermal fibroblasts 1984; Banda et al., 1987; Weiss, 1989). Although methio-
(Bullard et al., 1999), through an unknown substrate, nine, an HOCl scavenger, can reduce the NE-mediated
while in the mammary gland cell surface molecules, such subepidermal blistering and alter inactivation of a1-PI
as E-cadherin on epithelial cells are the implicated tar- by z23% in vivo in experimental BP (data not shown),
gets of stromelysin-1 (Sternlicht et al., 1999). proteolytic inactivation clearly is the major mechanism.
The present study shows a1-PI is the substrate for The mechanisms documented in this study are appli-
GB in skin blisters. However, it is unlikely to be the cable to human BP, which is rich in eosinophils that
GB target resulting in VEGF bioavailability required for also express GB, and to PMN-mediated inflammatory
angiogenesis during endochondral ossification. (Vu et diseases in general. Indeed, inactivated a1-PI has been
al., 1998). What all of these studies suggest is that ECM detected in fluids recovered from inflammatory sites in
molecules are not the rate-limiting substrates for MMPs vivo, in patients with rheumatoid arthritis, adult respira-
in many situations. tory distress syndrome and emphysema (Wong and
It has long been hypothesized that NE-mediated tis- Travis, 1980; Cochrane et al., 1983; Janoff, 1983; Wei-
sue destruction in certain inflammatory diseases, such land et al., 1986; Zhang et al., 1990; Belaaouaj et al.,
as emphysema, is caused by an imbalance in the ratio 1998). The involvement of both GB and NE in the patho-
of NE to a1-PI (Weiss, 1989). Our findings provide the genesis of the blistering disease BP give us new insights
into the immunopathogenic mechanisms in autoimmunefirst in vivo evidence that this mechanism, mediated by
MMP-9 Inactivates Serpins In Vivo
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(OD460 nm/mg protein of the mouse skin injected with pathogenic anti-diseases and implies both enzymes are potential targets
mBP180 IgG minus OD460 nm/mg protein of the mouse skin injectedfor therapeutic intervention.
with control IgG). Protein concentrations were determined by theOur results demonstrate that the important activities
Bio-Rad dye binding assay using BSA as a standard.of GB in physiology and pathology in vivo are dramati-
GB in protein extracts of PMN and skin sections from injected
cally different from those postulated from in vitro stud- animals was determined by gelatin gel zymography as described
ies. Moreover the substrates can be synthesized in dis- previously (Liu et al., 1998). The gels were stained with 0.125%
tant tissues, and thus be invisible to mRNA microarray Coomassie Brilliant blue. Areas of gelatinolytic activity appear as
and related analyses. Elucidating the precise substrates clear zones against a dark blue background.
NE activity in skin and PMN extracts of mice was measured usingof GB and other MMPs in vivo has the promise of uncov-
the NE-specific substrate methoxysuccinyl-Ala-Ala-Pro-Val-p-nitro-ering other novel extracellular regulatory and signaling
anilide (Met-O-Suc-Ala-Ala-Pro-Val-pNA, Enzyme Systems Prod-pathways.
ucts, Dublin, CA; Nakajima et al., 1979).
Experimental Procedures
Analysis of BP180 Cleavage
Intact mBP180 and its degradation products in mouse skin were
Animals
identified by SDS-PAGE (7%) followed by immunoblotting (Liu et
BALB/c mice were purchased from Jackson Laboratories (Bar Har-
al., 1995a), using rabbit anti-mBP180 IgG and monospecific FITC-
bor, ME). GB2/2 and matched normal control (GB1/1), NE2/2 and
conjugated goat anti-rabbit IgG (Kirkeggard & Perry Laboratories
matched normal control (NE1/1) mice were generated as described
Inc., Gaithersburg, MD).
(Belaaouaj et al., 1998; Vu et al., 1998). Breeding pairs of these
mice were maintained at the Medical College of Wisconsin Animal
Analysis of Dermal–Epidermal Separation In VitroResource Center. Neonatal mice, 24–36 hr old, weighing 1.4–1.6 g
Mouse skin sections were obtained from neonatal BALB/c mice (36were used for passive transfer experiments.
to 48 hr old) and cut into 2 3 2 mm strips with a razor blade. The
skin strips were then incubated in Minimum Essential Medium (MEM)
BP 180 Antibodies and Induction of Experimental BP Blisters either with or without 25 mg/ml human NE (Athens Research and
For preparation of pathogenic rabbit anti-murine BP180 IgG, recom- Technology Inc., Athens, GA) or 80 mg/ml mouse gelatinase B (Triple
binant murine BP180 and the immunization of rabbits were prepared Point Biologics, Forest Grove, OR) at 378C for various periods of
and the titers of rabbit anti-mBP180ABC antibodies in the rabbit time. At the end of the incubation, the skin strips were rinsed in
sera and in the purified IgG fractions were assayed by indirect IF fresh MEM, fixed in 10% formalin, and embedded in paraffin, sec-
using mouse skin cryosections as substrate, as reported previously tioned and stained with H&E.
(Liu et al., 1993). The pathogenicity of IgG preparations was tested
by passive transfer experiments. IgG from several rabbits were used Analysis of a1-PI
during these experiments with similar results.
a1-PI in the skin was detected by SDS-PAGE (10%) followed by
For induction of experimental BP and clinical evaluation, neonates immunoblotting using a rabbit anti-human a1-PI antiserum (Athens
were given one intradermal (i.d.) injection (50 ml each, 2.5 mg/g body Research and Technology Inc., Athens, GA) that cross-reacts with
weight) of a sterile solution of IgG in PBS, as described elsewhere murine a1-PI. To determine the levels of native (active) a1-PI in
(Liu et al., 1993, 1995b). The skin of neonatal mice from the test and the skin, the skin extracts were analyzed by reverse casein gel
control groups was examined 4, 12, or 24 hr after the IgG injections. zymography (Twining et al., 1996). Briefly, protein extracts of skin
The activity of cutaneous disease was scored as follows: “0”, no sections from injected animals were subjected to SDS-PAGE on
detectable skin disease; “1”, mild erythematous reaction with no polyacrylamide gels containing casein (10% acrylamide and 1%
evidence of epidermal detachment elicited by gentle friction of the casein) under nonreducing conditions. After electrophoresis gels
skin, which, when positive, produced fine, persistent wrinkling of were washed twice with 2.5% Triton X-100 for 30 min to remove SDS.
the epidermis; “2”, intense erythema and epidermal detachment Gels were then rinsed briefly with water and incubated overnight at
involving 10%–50% of the epidermis in the injection site; and “3”, 378C in chymotrypsin digestion solution (50 mg chymotrypsin/ml
intense erythema with frank epidermal detachment involving more casein gel reaction buffer). The gels were stained with 0.125% Coo-
than 50% of the epidermis in the injection site. massie Brilliant blue. a1-PI-protected areas appeared as blue bands
against a transparent background. The band density was quantified
Isolation of PMN by densitometric scanning using the Molecular Dynamics Storm 860
PMN were isolated from heparinized blood from GB2/2, GB1/1, scanner (Molecular Dynamics, Inc., Sunnyvale, CA). The level of a1-
NE2/2, or NE1/1 mice by dextran sedimentation followed by separa- PI was expressed as relative a1-PI units/mg protein (OD units/mg
tion on a density gradient (Coligan et al., 1994). PMN purity of the protein of the mouse skin injected with pathogenic anti-mBP180
final cell preparation was consistently .96% as determined by cell- IgG minus OD units/mg protein of the mouse skin injected with
cytospin and LeukoStat staining (Fisher Diagnostics, Orangeburg, control IgG).
NY). The viability of the PMN was .96% as determined by trypan
blue exclusion. For in vivo reconstitution of PMN mice were injected Injection of a1-PI
i.d. with pathogenic anti-mBP180 IgG (2.5 mg/g body weight in 50 Wild-type mice were injected with human a1-PI or a1-AC (i.p. 100
ml PBS). Two hours later, these mice were injected with 5 3 105 or mg/g body weight in PBS; Athens Research and Technology Inc.,
2.5 3 106 PMN i.d. (in 100 ml of PBS/10 mM glucose) at the same Athens, GA) prior to injection of pathogenic IgG. Skin was examined
site (Liu et al., 1998). The animals were analyzed 4 or 12 hr after the at 4 and 12 hr for clinical lesions. Injected areas were excised and
IgG injections. extracted for analysis of PMN infiltration by MPO assay.
Statistical AnalysisMPO, GB, and NE
For statistical analysis, the data were expressed as mean 6 SEMFor quantification of PMN accumulation in the skin, tissue myeloper-
and were analyzed using Student’s t test. A p value less than 0.05oxidase (MPO) activity in skin sites of the injected animals was
was considered significant.assayed as described (Bradley et al., 1982), using purified MPO
(Athens Research and Technology Inc., Athens, GA) as standard.
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